4月22日,港股市场集体震荡环境下,港股医药带头领涨,港股医药ETF(159718)上涨3.10%,冲击4连涨。最新价报0.7元。成分股石药集团、百济神州、信达生物、再鼎医药、康方生物上涨超 5%。消息面上,北京市已有10个试验项目顺利纳入国家创新药临床试验审评审批试点,其中,8个项目获批临床试验,审评审批平均用时23.8个工作日,最短用时18个工作日,最高提速70%。项目自获批至启动(首例受试者...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.